Literature DB >> 21862947

Severe visual loss and orbital infarction following periorbital aesthetic poly-(L)-lactic acid (PLLA) injection.

Steve A I Roberts1, Bryan P Arthurs.   

Abstract

Visual loss following esthetic treatment of the face is a rare but devastating iatrogenic complication. The authors report a case of a 43-year-old man with blindness and ophthalmoplegia of the left eye following a treatment of the left periorbital region with the subcutaneous filler poly-(L)-lactic acid. The patient's symptoms began immediately following one of the tunneled injections. On presentation, the patient had clear signs of ocular and orbital ischemia. Angiography and further history suggested an embolic orbital infarction as the mechanism of injury. The increased usage of subcutaneous fillers for facial rejuvenation had introduced a small but proven risk of embolization of these viscous materials to the eye and orbit.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21862947     DOI: 10.1097/IOP.0b013e3182288e4d

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  4 in total

1.  Alopecia Secondary to Hyaluronic Acid Embolization: Trichoscopic Findings.

Authors:  Daniel Asz-Sigall; Karla Iñigo-Gomez; María Fernanda Ortega-Springall; María Elisa Vega-Memije; Roberto Arenas; Antonella Tosti
Journal:  Skin Appendage Disord       Date:  2019-09-18

2.  Partial vision recovery after iatrogenic retinal artery occlusion.

Authors:  Shu-Fang Hsiao; Yi-Hsun Huang
Journal:  BMC Ophthalmol       Date:  2014-10-11       Impact factor: 2.209

3.  Solubility and ADMET profiles of short oligomers of lactic acid.

Authors:  Daniela Dascălu; Diana Larisa Roman; Madalina Filip; Alecu Ciorsac; Vasile Ostafe; Adriana Isvoran
Journal:  ADMET DMPK       Date:  2020-06-28

4.  Isolated Ophthalmoplegia Following Filler Injections to the Upper Face.

Authors:  Elaine M Downie; Yanjun Chen; Mark J Lucarelli; Cat N Burkat
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2020 Nov/Dec       Impact factor: 1.746

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.